Glucose Concentration in Regulating Induced Pluripotent Stem Cells Differentiation Toward Insulin-Producing Cells
Transplant International · 2024
DOI: 10.3389/ti.2024.11900 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Chencheng Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Transplant Medicine, Institute for Surgical Research, Oslo University Hospital, Oslo, Norway. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Insulin-Secreting Cells. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The generation of insulin-producing cells from human-induced pluripotent stem cells holds great potential for diabetes modeling and treatment. However, existing protocols typically involve incubating cells with un-physiologically high concentrations of glucose, which often fail to generate fully functional IPCs. Here, we investigated the influence of high (20 mM) versus low (5.5 mM) glucose concentrations on IPCs differentiation in three hiPSC lines. In two hiPSC lines that were unable to differentiate to IPCs sufficiently, we found that high glucose during differentiation leads to a shortage of NKX6.1+ cells that have co-expression with PDX1 due to insufficient NKX6.1 gene activation, thus further reducing differentiation efficiency. Furthermore, high glucose during differentiation weakened mitochondrial respiration ability. In the third iPSC line, which is IPC differentiation amenable, glucose concentrations did not affect the PDX1 / NKX6.1 expression and differentiation efficiency. In addition, glucose-stimulated insulin secretion was only seen in the differentiation under a high glucose condition. These IPCs have higher KATP channel activity and were linked to sufficient ABCC8 gene expression under a high glucose condition. These data suggest high glucose concentration during IPC differentiation is necessary to generate functional IPCs. However, in cell lines that were IPC differentiation unamenable, high glucose could worsen the situation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Transplant Medicine, Institute for Surgical Research, Oslo University Hospital, Oslo, Norway.
- Hybrid Technology Hub, Center of Excellence, University of Oslo, Oslo, Norway.
- Department of Immunology and Transfusion Medicine, Oslo University Hospital, Oslo, Norway.
- Department of Molecular Medicine, Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
- Department of Clinical Science, University of Bergen, Bergen, Norway.
- Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.
Zitieren
APA
Wang, C., Abadpour, S., Olsen, P. A., Wang, D., Stokowiec, J., Chera, S., Ghila, L., Ræder, H., Krauss, S., Aizenshtadt, A., & Scholz, H. (2024). Glucose Concentration in Regulating Induced Pluripotent Stem Cells Differentiation Toward Insulin-Producing Cells. Transplant International. https://doi.org/10.3389/ti.2024.11900
Vancouver
Wang C, Abadpour S, Olsen PA, Wang D, Stokowiec J, Chera S, et al. Glucose Concentration in Regulating Induced Pluripotent Stem Cells Differentiation Toward Insulin-Producing Cells. Transplant International. 2024. doi:10.3389/ti.2024.11900
BibTeX
@article{Wang2024,
author = {Wang, Chencheng and Abadpour, Shadab and Olsen, Petter Angell and Wang, Daxin and Stokowiec, Justyna and Chera, Simona and Ghila, Luiza and Ræder, Helge and Krauss, Stefan and Aizenshtadt, Aleksandra and Scholz, Hanne},
title = {Glucose Concentration in Regulating Induced Pluripotent Stem Cells Differentiation Toward Insulin-Producing Cells},
journal = {Transplant International},
year = {2024},
doi = {10.3389/ti.2024.11900}
}
EUVIMED